Ann Tucker
- Feb 19, 2021
- 1 min read

Medication Options for Treatment of Stimulant Use Disorders: Optimistic Update and New Research

TUESDAY, MARCH 2nd / 12:00-1:00pm CT

Overdose deaths associated with illicit stimulants have surged in the past eight years, according to a recent study by the National Institutes for Health (NIH). While there are currently no FDA-approved medications for the treatment of individuals who are dependent on stimulants, new treatments utilizing readily available medications are showing encouraging empirical support.

Join the National Council for Behavioral Health as we examine the latest groundbreaking research in the context of current increases in stimulant use. Register here

Recent Posts

See All

Oversight Hearing Held on ONDCP Reauthorization

U.S. House | This week, the House Oversight and Accountability Committee held a hearing on “Oversight and Reauthorization of the Office of National Drug Control Policy." Dr. Rahul Gupta, ONDCP Directo

Senate Appropriators Advance Modest Substance Use, Mental Health Block Grant Increases in Spending

U.S. Senate | Last week, the Senate Appropriations Committee passed a FY24 funding bill for several priority agencies including the Substance Abuse and Mental Health Services Administration (SAMHSA),

Between April-May 2023, Nearly 14% of Louisiana 988 Calls Went Unanswered

Axios [2-Aug] | Nearly 14% of the 5,065 988 calls made across Louisiana went unanswered by in-state counselors between April and May, per a new analysis from health research outlet KFF. Those calls we

Medication Options for Treatment of Stimulant Use Disorders: Optimistic Update and New Research

Recent Posts

Subscribe to the CLASPP Newsletter

Email:

Phone: